{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:09:23Z","timestamp":1778573363603,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21272273"],"award-info":[{"award-number":["21272273"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bmcl.2026.130657","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T09:04:53Z","timestamp":1775898293000},"page":"130657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, and radioprotection activity evaluation of 1H-1,2,3-triazole derivatives as TLR2\/1 small molecule agonists"],"prefix":"10.1016","volume":"137","author":[{"given":"Hao","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinru","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenteng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuchen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bmcl.2026.130657_bb0005","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1080\/17460441.2019.1604674","article-title":"Drug discovery strategies for acute radiation syndrome","volume":"14","author":"Singh","year":"2019","journal-title":"Expert Opin Drug Discov"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130657_bb0010","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.emc.2013.10.002","article-title":"Ionizing radiation injuries and illnesses","volume":"32","author":"Christensen","year":"2014","journal-title":"Emerg Med Clin North Am"},{"issue":"4","key":"10.1016\/j.bmcl.2026.130657_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2025.101599","article-title":"Cytokine therapy of acute radiation syndrome","volume":"37","author":"Lazarus","year":"2024","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.bmcl.2026.130657_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100690","article-title":"Use of molecularly-cloned haematopoietic growth factors in persons exposed to acute high-dose, high-dose rate whole-body ionizing radiations","volume":"45","author":"Gale","year":"2021","journal-title":"Blood Rev"},{"issue":"6","key":"10.1016\/j.bmcl.2026.130657_bb0025","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1667\/RR13940.1","article-title":"Pegfilgrastim improves survival of lethally irradiated nonhuman Primates","volume":"183","author":"Hankey","year":"2015","journal-title":"Radiat Res"},{"issue":"11","key":"10.1016\/j.bmcl.2026.130657_bb0030","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1007\/s12325-023-02636-5","article-title":"Pharmacokinetic and pharmacodynamic bioequivalence of pegfilgrastim-cbqv delivered via a prefilled autoinjector and prefilled syringe in healthy male participants","volume":"40","author":"Tang","year":"2023","journal-title":"Adv Ther"},{"issue":"5873","key":"10.1016\/j.bmcl.2026.130657_bb0035","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1126\/science.1154986","article-title":"An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models","volume":"320","author":"Burdelya","year":"2008","journal-title":"Science"},{"issue":"24","key":"10.1016\/j.bmcl.2026.130657_bb0040","doi-asserted-by":"crossref","first-page":"38602","DOI":"10.18632\/oncotarget.16199","article-title":"Effects of TLR-2\/NF-\u03baB signaling pathway on the occurrence of degenerative knee osteoarthritis: an in vivo and in vitro study","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bmcl.2026.130657_bb0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.semcdb.2014.12.007","article-title":"Survivin - the inconvenient IAP","volume":"39","author":"Altieri","year":"2015","journal-title":"Semin Cell Dev Biol"},{"issue":"9","key":"10.1016\/j.bmcl.2026.130657_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135388","article-title":"The toll-like receptor 5 agonist entolimod mitigates lethal acute radiation syndrome in non-human Primates","volume":"10","author":"Krivokrysenko","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bmcl.2026.130657_bb0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijbiomac.2015.10.033","article-title":"CBLB502, an agonist of toll-like receptor 5, has antioxidant and scavenging free radicals activities in vitro","volume":"82","author":"Li","year":"2016","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"10.1016\/j.bmcl.2026.130657_bb0060","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1084\/jem.175.3.689","article-title":"Role of interleukin 6 (IL-6) in protection from lethal irradiation and in endocrine responses to IL-1 and tumor necrosis factor","volume":"175","author":"Neta","year":"1992","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.bmcl.2026.130657_bb0065","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood.V95.3.837.003k08_837_845","article-title":"Myelopoietin, an engineered chimeric IL-3 and G-CSF receptor agonist, stimulates multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression","volume":"95","author":"Macvittie","year":"2000","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130657_bb0070","doi-asserted-by":"crossref","first-page":"17355","DOI":"10.1038\/s41598-017-17729-9","article-title":"The toll-like receptor 2\/6 agonist, FSL-1 lipopeptide, therapeutically mitigates acute radiation syndrome","volume":"7","author":"Kurkjian","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130657_bb0075","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1667\/RR2657.1","article-title":"CBLB613: a TLR 2\/6 agonist, natural lipopeptide of Mycoplasma arginini, as a novel radiation countermeasure","volume":"177","author":"Singh","year":"2012","journal-title":"Radiat Res"},{"key":"10.1016\/j.bmcl.2026.130657_bb0080","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2121095","article-title":"TLR4 agonist monophosphoryl lipid a alleviated radiation-induced intestinal injury","volume":"2019","author":"Guo","year":"2019","journal-title":"J Immunol Res"},{"issue":"6","key":"10.1016\/j.bmcl.2026.130657_bb0085","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1269\/jrr.10098","article-title":"Radioprotection of bone marrow hematopoiesis by CpG-oligodeoxynucleotides administered to mice after total-body irradiation","volume":"52","author":"Zhang","year":"2011","journal-title":"J Radiat Res"},{"issue":"7","key":"10.1016\/j.bmcl.2026.130657_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13071006","article-title":"Re-assessing PK\/PD issues for oral protein and peptide delivery","volume":"13","author":"Mrsny","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bmcl.2026.130657_bb0095","article-title":"The role of TLR2 in infection and immunity","volume":"3","author":"De Oliviera Nascimento","year":"2012","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130657_bb0100","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130657_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2009.08.010","article-title":"Toll-like receptor signaling in cell proliferation and survival","volume":"49","author":"Li","year":"2010","journal-title":"Cytokine"},{"issue":"11","key":"10.1016\/j.bmcl.2026.130657_bb0110","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1111\/j.1582-4934.2010.01127.x","article-title":"Endogenous toll-like receptor ligands and their biological significance","volume":"14","author":"Yu","year":"2010","journal-title":"J Cell Mol Med"},{"issue":"43","key":"10.1016\/j.bmcl.2026.130657_bb0115","doi-asserted-by":"crossref","first-page":"14440","DOI":"10.1021\/jacs.8b09223","article-title":"Diprovocims: A new and exceptionally potent class of toll-like receptor agonists","volume":"140","author":"Morin","year":"2018","journal-title":"J Am Chem Soc"},{"issue":"10","key":"10.1016\/j.bmcl.2026.130657_bb0120","article-title":"TLR1\/2 specific small-molecule agonist suppresses leukemia cancer cell growth by stimulating cytotoxic t lymphocytes","volume":"6","author":"Cen","year":"2019","journal-title":"Adv Sci Weinh"},{"issue":"6","key":"10.1016\/j.bmcl.2026.130657_bb0125","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1021\/acs.jmedchem.3c01984","article-title":"Design and synthesis of 3-(2H-Chromen-3-yl)-5-aryl-1,2,4-oxadiazole derivatives as novel toll-like receptor 2\/1 agonists that inhibit lung cancer in vitro and in vivo","volume":"67","author":"Wang","year":"2024","journal-title":"J Med Chem"},{"issue":"81","key":"10.1016\/j.bmcl.2026.130657_bb0130","doi-asserted-by":"crossref","first-page":"11411","DOI":"10.1039\/C8CC06618C","article-title":"Structure-based discovery of a specific TLR1-TLR2 small molecule agonist from the ZINC drug library database","volume":"54","author":"Chen","year":"2018","journal-title":"Chem Commun (Camb)"},{"issue":"11","key":"10.1016\/j.bmcl.2026.130657_bb0135","doi-asserted-by":"crossref","first-page":"7371","DOI":"10.1021\/acs.jmedchem.0c02266","article-title":"Design, synthesis, and structure\u2013activity relationship of N-aryl-N\u2032-(thiophen-2-yl)thiourea derivatives as novel and specific human TLR1\/2 agonists for potential cancer immunotherapy","volume":"64","author":"Chen","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130657_bb0140","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejmech.2019.02.067","article-title":"Synthesis of urea analogues bearing N-alkyl-N\u2019-(thiophen-2-yl) scaffold and evaluation of their innate immune response to toll-like receptors","volume":"169","author":"Chen","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130657_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103845","article-title":"Molecular medicinal insights into scaffold hopping-based drug discovery success","volume":"29","author":"Acharya","year":"2024","journal-title":"Drug Discov Today"},{"issue":"10","key":"10.1016\/j.bmcl.2026.130657_bb0150","doi-asserted-by":"crossref","first-page":"7788","DOI":"10.1021\/acs.jmedchem.4c00652","article-title":"Triazoles in medicinal chemistry: physicochemical properties, bioisosterism, and application","volume":"67","author":"Guan","year":"2024","journal-title":"J Med Chem"},{"issue":"9","key":"10.1016\/j.bmcl.2026.130657_bb0155","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1021\/ol070527h","article-title":"Efficient conversion of aromatic amines into azides: A one-pot synthesis of triazole linkages","volume":"9","author":"Barral","year":"2007","journal-title":"Org Lett"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130657_bb0160","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1021\/ol049915z","article-title":"Parallel synthesis of terminal alkynes using a ROMPgel-supported ethyl 1-diazo-2-oxopropylphosphonate","volume":"6","author":"Barrett","year":"2004","journal-title":"Org Lett"},{"issue":"10","key":"10.1016\/j.bmcl.2026.130657_bb0165","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1021\/jo4003097","article-title":"Synthesis of robalzotan, ebalzotan, and rotigotine precursors via the stereoselective multienzymatic cascade reduction of \u03b1,\u03b2-unsaturated aldehydes","volume":"78","author":"Brenna","year":"2013","journal-title":"J Org Chem"},{"issue":"11","key":"10.1016\/j.bmcl.2026.130657_bb0170","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1517\/13543776.2014.964684","article-title":"Radiation countermeasure agents: an update (2011-2014)","volume":"24","author":"Singh","year":"2014","journal-title":"Expert Opin Ther Pat"},{"issue":"9","key":"10.1016\/j.bmcl.2026.130657_bb0175","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1080\/09553002.2017.1338782","volume":"93","author":"Singh","year":"2017","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.bmcl.2026.130657_bb0180","unstructured":"Lirong YI,Limei WANG, Yajun SHAN,et al. Radiation protection effect and its mechanism of multiple nilestriol administrations on the mice with bone marrow type of acute radiation syndrome Chinese Journal of Radiological Medicine and Protection;2016;36(6):412\u2013418, Chin J Radiol Med Prot."},{"issue":"3","key":"10.1016\/j.bmcl.2026.130657_bb0185","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2023.12953","article-title":"Radioprotective countermeasures for radiation injury (review)","volume":"27","author":"Liu","year":"2023","journal-title":"Mol Med Rep"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26001241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26001241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:22:23Z","timestamp":1778570543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X26001241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":37,"alternative-id":["S0960894X26001241"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130657","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and radioprotection activity evaluation of 1H-1,2,3-triazole derivatives as TLR2\/1 small molecule agonists","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130657","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130657"}}